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CTLA-4 deﬁcient mice show severe lymphoproliferative disorders with T helper sub-population
skewed toward the Th2 phenotype. In the present work, we investigated the role of CTLA-4 in T helper
cell subset differentiation. Naı ¨ve CD4
þ cells were stimulated with anti-CD3 and anti-CD28 mAbs in
the presence of either IL-12 or IL-4 to induce polarisation to Th1 or Th2 cells, respectively. Under these
two polarising conditions cells express comparable levels of CTLA-4. CTLA-4 was stimulated by
plastic-bound mAb. The frequency of IFN-g- and IL-4-producing cells were estimated by FACS
analysis. In parallel cultures, polarised Th1 and Th2 cells were re-stimulated with anti-CD3 and anti-
CD28 mAbs for 48h and their culture supernatants analysed by ELISA. Results show that CTLA-4
engagement during differentiation inhibits polarisation of naı ¨ve CD4
þ cells to the Th2 but not the Th1
cell subset. At variance, once cells are polarised, CTLA-4 engagement inhibits cytokine production in
both effector Th2 and Th1 cells. Altogether these data indicate that CTLA-4 may interfere not only in
the signalling involved in acute transcriptional activation of both Th1 and Th2 cells but also in the
development of one of the Th cell subsets.
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INTRODUCTION
TCR ensures antigen speciﬁcity and MHC restriction
of T cell activation. Additional signals delivered by
co-stimulatory molecules and cytokines sustain and
integrate TCR signalling resulting in optimal cell
proliferation and differentiation. Upon activation, naı ¨ve
CD4 cells differentiate in subsets displaying different
cytokine patterns. Th1 cells produce IL-2 and IFN-g, and
promote cell-mediated immune responses, whereas Th2
cells secrete IL-4, IL-5, IL-6 and IL-13, and sustain
humoral responses. Micro-environment/milieu at priming
conditions naı ¨ve CD4
þ differentiation. IL-12 produced by
dendritic cells induces Th1 differentiation, whereas IL-4
produced by other T cells promotes differentiation to Th2
cells. In addition to cytokines, several factors such as
intensity of TCR signal, costimulation, type of APC and
genetic background have been shown to affect Th cell
differentiation (Abbas et al., 1996; Constant and
Bottomly, 1997; O’Garra, 1998).
CD28, the main co-stimulatory receptor, plays an
important role in T cell activation up-regulating
cytokine production, CD25 expression and cell pro-
liferation. CD28 engagement by CD80 (B7.1) and
CD86 (B7.2) expressed on APC, promotes Th2 subset
differentiation in vitro (Webb and Feldmann, 1995;
Rulifson et al., 1997) and in vivo (King et al., 1996).
A second receptor for B7 molecules, CTLA-4 (CD152),
is up-regulated on activated T cells with maximum of
expression at 48h. It exerts a negative role in T cell
activation inhibiting factors required for cytokine
production and cell proliferation (Krummel and Allison,
1996; Walunas et al., 1996; Pioli et al., 1999).
The critical role played by this receptor is evident in
CTLA-4 deﬁcient mice which develop dramatic
lymphoproliferative disorders and die by 1 month of
age (Tivol et al., 1995; Waterhouse et al., 1995).
In these mice, all immunoglobulin isotypes show higher
basal serum levels as compared to wild-type mice,
ranging from 10-fold for IgM, IgG2a,I g G 2b and IgG3,t o
100-fold for IgG1 and IgA, to several thousand fold for
IgE (Waterhouse et al., 1995). CD4 cells from CTLA-4
deﬁcient mice display higher cytokine production as
compared to the wild type counterpart, IL-4 being much
more increased than IFN-g production (Khattri et al.,
1999). Moreover, lack of CTLA-4 during antigen-
dependent activation in transgenic CD4 cells results in
differentiation to Th2 cells (Oosterwegel et al., 1999).
These data all together prompted us to investigate the
role of CTLA-4 during T helper cell polarisation.
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Cell Puriﬁcation and Cultures
Splenic naı ¨ve CD4
þ T cells from C57Bl/6 mice were
puriﬁed by immunomagnetic cell sorting according to the
manufacturer’s instructions (Miltenyi, catalogue numbers
130-058-701 and 130-049-701). Collected cells were
found to be almost exclusively (.95%) CD4
þCD45RB
hi
by ﬂow cytometry analysis. To induce Th cell polarisation,
naı ¨ve CD4
þ cells were cultured in plates pre-coated with
anti-CD31 mAb (clone 145-2C11; 10mg/ml). Anti-CD28
mAb (clone 37.51) was used in soluble form (1mg/ml).
InTh1polarisingcultures,IL-12(10ng/ml)andananti-IL-
4 blocking mAb were added. In Th2 polarising cultures,
IL-4 (5ng/ml) and an anti-IFN-g blocking mAb were
added. Anti-CTLA-4 mAb (clone UC10-4F10-11) or
hamster IgG (isotype control) was bound to plates at
the concentration of 10mg/ml. Polarised cells were
re-stimulated with PMA and ionomycin for 5h, in the
presenceofbrefeldinA,orfor48htoanalysethefrequency
of cytokine-producing cells and cytokine release in
supernatants, respectively. Polarised cells were also
re-stimulated with bound anti-CD3 and soluble anti-
CD28mAbfor48h.Alltheantibodiesemployedinculture
were sodium azide- and endotoxin-free as certiﬁed by the
producer (Pharmingen).
Cytokine Titration
Cytokines were titrated in culture supernatants by
sandwich ELISA as already described (Pioli et al.,
1998). The reference straight line obtained by plotting the
absorbance versus the standard cytokine concentrations
was used to calculate cytokine concentrations in the
supernatants.
Flow Cytometry Analysis
Cells were pre-incubated with Fc Block (anti-CD16/32,
clone2.4G2)topreventcytophilicbindingoflabelled Abs.
Cytokine-producingcellswererevealedbydouble-staining
cells with PE-conjugated anti-IL-4 mAb (clone BVD4-
1D11) and FITC-conjugated anti-IFN-g mAb (clone
XMG1.2). Intracellular CTLA-4 was revealed with a PE-
conjugated anti-CTLA-4 mAb (clone UC10-4F10-11).
Before staining cells were permeabilised with saponin
(5%) and ﬁxed with paraformaldehyde (2%). PE/FITC-
conjugated isotype-matched Abs were used as controls.
The optimal concentrations of all the Abs were assessed in
preliminary experiments. Samples of viable 20 £ 10
4cells
were analysed, and ﬂuorescence signals collected in log
mode using a FACScalibur (Becton Dickinson).
RT-PCR
Total RNA extracted by TRIzol Reagent (Life Techno-
logies) was used as template for cDNA synthesis
performed by Perkin-Elmer GeneAmp RNA PCR kit.
After an initial 5-min denaturation at 948C, the cDNAwas
ampliﬁed for 35 cycles; each cycle was programmed
for denaturation at 948C for 45s, annealing at 488C
for 60s, and elongation at 728C for 90s. The following
oligonucleotides were used as primers: b-actin for-
ward, 50-CTGAAGTACCCATTGAACATGGC; b-actin
reverse, 50-CAGAGCAGTAATCTCCTTCTGCAT; IL-4
mRNA forward, 50-TATTGATGGGTCTCAACCCC; IL-4
mRNA reverse, 50-TCCATTTGCATGATGCTCTT.
RESULTS
Cytokine Production and CTLA-4 Expression during
Th Cell Polarisation
Puriﬁed naı ¨ve CD4
þ cells were stimulated with anti-CD3,
anti-CD28 in the presence of IL-12 and anti-IL-4 blocking
mAb and IL-12 to induce differentiation toward Th1 cells
(hereafter Th1 condition). Differentiation to Th2 cells was
induced by anti-CD3, anti-CD28, IL-4 and anti-IFN-g
blocking mAb (hereafter Th2 condition). To verify that
naı ¨ve CD4
þ cells differentiating to Th1 and Th2 cells
were actually producing polarised cytokines we analysed
culture supernatants by ELISA and/or mRNA expression
by RT-PCR. Under Th1 condition CD4
þ cells produced
large amounts of IFN-g whereas IL-5 and IL-10 were
barely detectable (Fig. 1, panel A). Under Th2 condition,
IL-4 produced by CD4
þ cells cannot be distinguished
from the IL-4 we added in culture and thus, we analysed
IL-4 mRNA expression by RT-PCR. Results show that
during Th2 polarisation, CD4
þ cells express high levels
of IL-4 mRNA (panel B), which increases with the
stimulation time, and produce IL-5 and IL-10 but not
IFN-g (panel A).
In CD4
þ cell bulk cultures CTLA-4 expression
increases with stimulation time reaching a maximum
after 48–72h. Under polarising conditions, naı ¨ve CD4
þ
cells might be induced by IL-12 or IL-4 to express
different levels of CTLA-4. Toverify this hypothesis naı ¨ve
CD4
þ cells were stimulated under Th1 or Th2 conditions
and analysed for CTLA-4 expression by intracellular and
surface staining at different stimulation times. As shown
in Fig. 1, panels C and D, Th1 and Th2 polarising
conditions induce comparable levels of intracellular
CTLA-4 expression. Also the kinetics is similar in both
groups, the expression being higher at 3–5 days and lower
after 1 week of stimulation. Unstimulated naı ¨ve CD4
þ
cells do not express CTLA-4. Surface staining was barely
detectable under both Th1 and Th2 polarising conditions
(not shown).
CTLA-4 Engagement Inhibits Th2 but not Th1 Cell
Polarisation
Puriﬁednaı ¨veCD4
þcellswerestimulatedunderTh1orTh2
polarisingconditionsinthe presenceofeitherplastic-bound
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After 1 week, polarisation cells were collected and
re-stimulated with PMA and ionomycin for 5h in the
presence of brefeldin A to induce massive cytokine produc-
tion and retention in intracellular compartments. Cells were
then doubled-stained with FITC-conjugated anti-IFN-g and
PE-conjugated anti-IL-4 or isotype control mAbs (Table I).
Flow cytometry analyses show that under Th1-polarising
conditions 28% of the cell population produce IFN-g
whereas very few cells (1.1%) produce IL-4 and apparently
nooneproducebothcytokines.CTLA-4engagementduring
Th1 polarisation does not affect the frequency of cytokine-
producing cells. In parallel cultures, polarised cells were
re-stimulated with PMA and ionomycin for 48h. ELISA
reveals that CTLA-4 engagement during Th1 polarisation
does not affect IFN-g production in re-stimulated cells.
ThesedataalltogetherindicatethatCTLA-4doesnotaffect
differentiation of naı ¨ve CD4
þ cells to Th1.
Conversely, when naı ¨ve CD4
þ cells are driven to
differentiate toward Th2 cells, CTLA-4 engagement
inhibits polarisation. CTLA-4 engagement, indeed,
reduces the frequency of IL-4 producing cells from 29
to 15% but without increasing IFN-g-producing cells
(Table I). Upon re-stimulation for 48h, cells polarised
in the presence of anti-CTLA-4 reveal a lower production
of IL-4 and IL-5 as compared to control cells.
The percentage of inhibition for IL-4 and IL-5 is 46 and
32%, respectively. Thus, CTLA-4 inhibits Th2 butnot Th1
cell polarisation.
FIGURE 1 Cytokine production and CTLA-4 expression during cell polarisation. Naive CD4
þ cells were stimulated under Th1 or Th2 polarising
conditions for 3, 5 or 7 days. (A) After 1 week, stimulation cytokine concentration of culture supernatants was evaluated by ELISA. (B) After 3 and 5
days stimulationIL-4 mRNA expression was evaluatedby RT-PCR. Ampliﬁed productswere fractionatedin a 2% ethidiumbromide-stained agarosegel.
Optical density of IL-4 mRNA bands were normalised to optical density of corresponding b-actin samples and values expressed as arbitrary units.
(C) After 3, 5 and 7 days stimulation cells were permeabilised, ﬁxed and intracellularly stained with PE-conjugated anti-CTLA-4 mAb. Values represent
percentage of positive cells. Not speciﬁc staining was evaluated with a isotype-matched PE-conjugated control mAb. (D) CTLA-4 mean ﬂuorescence
intensity. Each value represents the difference between the mean ﬂuorescence intensity of the sample stained with the PE-conjugated anti-CTLA-4 mAb
and the relevant sample stained with PE-conjugated control mAb.
TABLE I CTLA-4 engagement inhibits polarisation to Th2 cell subset
Polarising
stimuli
Cytokine producing
cells
(a)(%)
Cytokine
production
(b)(ng/ml)
IL-4
þ IFN-g
þ
IL-4
þ
IFN-g
þ IL-4 IL-5 IFN-g
Th1 þ iso ctrl 1.1 28.3 0.8 2.1 0.5 29.9
Th1 þ aCTLA-4 0.9 30.0 0.8 1.8 0.7 32.6
Th2 þ iso ctrl 29.1 0.8 0.7 16.3 4.8 2.4
Th2 þ aCTLA-4 15.2 1.3 1.0 8.7 3.2 2.7
Th1 and Th2 polarised cells were re-stimulated with PMA and ionomycin either
(a)for 5h in the presence of brefeldin A, double-stained with PE-conjugated anti-
IL-4 and FITC-conjugated anti-IFN-g mAb and analysed by ﬂow cytometry or
(b)for 48h and their culture supernatants analysed by ELISA. Iso ctrl: isotype
control mAb; aCTLA-4: anti-CTLA mAb.
CTLA-4 AFFECTS TH2 POLARISATION ONLY 15CTLA-4 Inhibits the Production of Effector Cytokines
in both Th1 and Th2 Cells
Polarised Th1 and Th2 cells were re-stimulated with anti-
CD3 and anti-CD28 mAb in the presence of either plastic-
bound anti-CTLA-4 mAb or hamster IgG (isotype
control). After 48h, culture supernatants were analysed
by ELISA. Figure 2 shows that CTLA-4 engagement
inhibits cytokine production according to the Th
speciﬁcity. IL-4 production was, indeed, inhibited in Th2
cells as well as IFN-g production in Th1 cells. Regardless
of CTLA-4 engagement, culture supernatants from
re-stimulated Th1 and Th2 cells were negative for IL-4
and IFN-g, respectively. These data suggest that CTLA-4
is functional in both Th1 and Th2 cells and that it can
negatively regulate effector cytokine production in both
polarised Th1 and Th2 cells.
DISCUSSION
CTLA-4 has been widely described to play a negative role
in T cell activation (Alegre et al., 2001). T cell CTLA-4
engagement, indeed, inhibits cytokine production, CD25
expression, and cell cycle progression (Walunas et al.,
1996; Brunner et al., 1999). Coherently, CTLA-4
blockade enhances T cell responses to Ags (Kearney
et al., 1995) and tumours (Leach et al., 1996) and
exacerbates auto-immune diseases (Karandikar et al.,
1996; Perrin et al., 1996). The timing for the inhibitory
effect of CTLA-4 engagement depends on the kinetics of
CTLA-4 expression. This receptor, indeed, reaches a
maximum of expression after 48h stimulation, indicating
a crucial role in shutting down T cell activities, after the
effector function has been turned on. In effector CD4
þ
cells CTLA-4 inhibits both IFN-g and IL-4 production,
as previously described (Alegre et al., 2001) and reported
in the present paper (Fig. 2). On the other hand, the Th2
skewed phenotype of CTLA-4 deﬁcient mice (Khattri
et al., 1999) raises the question as to whether CTLA-4
might play a role also in Th cell subset differentiation.
In the present paper, we show that CTLA-4 engagement
during naı ¨ve CD4
þ cell polarisation blocks differentiation
to Th2 but not to Th1 cell subset. Upon re-stimulation,
indeed, CD4 cells cultured for 1 week under Th2
polarising conditions in the presence of anti-CTLA-4
mAb show reduced frequency of IL-4-producing cells and
IL-4 and IL-5 production as compared to control group
(Table I). At variance, CTLA-4 engagement during
polarisation does not affect the frequency of IFN-g-
producing cells. This contrast could be due to a different
effect of CTLA-4 signals on transduction pathways
leading to Th1/Th2 differentiation. CTLA-4 has been
described to interfere with signals delivered by the
TCR/CD3 complex inhibiting LAT phosphorylation
(Lee et al., 1998). Inhibition of LAT activation could
explain inhibitory effects on downstream factors required
for “acute” gene transcription as it occurs in already
polarised (effector) CD4
þ cells. Cytokine mRNA
expression induced by TCR/CD28 costimulation in
polarised cells, indeed, occurs according to the cell subset
speciﬁcity also in the absence of polarising cytokines
(IL-12 or IL-4) (Table I and Fig. 2). During polarisation,
in the presence of IL-12 or IL-4, other signalling pathways
are also activated. Differentiation is reached by chromatin
remodelling driven by polarising cytokines. Under Th2
polarising conditions, this process leads to a better
accessibility of the IL-4/IL-5/IL-13 locus for transcription
factors and to a reduced accessibility of the IFN-g
promoter. It is possible that CTLA-4 interferes with the
activation of factors required for this process. Alterna-
tively, CTLA-4 by interfering with signals generated by
CD3/CD28 co-stimulation might block Th2 cell differen-
tiation sustained by CD28 stimulation. In a physiological
process, competition between CTLA-4 and CD28 for
binding to B7 ligands could also play role, especially
when B7 expression is limiting. We are currently
investigating these mechanisms.
In conclusion, our work shows that CTLA-4 plays a
dual role. It controls the production of effector cytokines
FIGURE2 Polarised Th1and Th2 cells were re-stimulated with anti-CD3and anti-CD28mAbin the presenceof either isotype control oranti-CTLA-4
mAb. After 48h culture supernatants were analysed by ELISA (n.d., not detectable).
V. UBALDI et al. 16in both Th1 and Th2 cells whereas it affects only naı ¨ve
CD4 cell differentiation to Th2.
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